joint product development agreementJoint Product Development Agreement • April 8th, 2016 • Cellect Biomed Ltd. • Biological products, (no disgnostic substances) • England and Wales
THIS JOINT PRODUCT DEVELOPMENT AGREEMENT (“Agreement”), effective as of the 17th day of June, 2015 (“Effective Date”), is made and entered into by and between CELLECT BIOMED LTD., an Israeli corporation with its principal office located at 10 Hataas Street, Kfar Saba, Israel (“Cellect”), and ENTEGRIS, INC., a Delaware corporation with its principal office located at 129 Concord Road Billerica, MA 01821 (“Entegris”). Each of Cellect and Entegris are sometimes hereinafter referred to as a “Party” and collectively as the “Parties”.
EMPLOYMENT AGREEMENTEmployment Agreement • April 8th, 2016 • Cellect Biomed Ltd. • Biological products, (no disgnostic substances)
This employment agreement (the “Agreement”) dated as of October 14, 2015, effective as of November 3, 2015 (the “Effective Date”), by and between Cellect Biomed Ltd., an Israeli company, with offices at 20 Hataas St., Kfar Saba, Israel(hereinafter the “Company”), and Ronen Twito I.D. Number: 032161655, an individual whose address is Yehuda Hanassi 8a, Herzeliya, Israel (the “Employee”),
FOUNDERS AGREEMENTFounders Agreement • April 8th, 2016 • Cellect Biomed Ltd. • Biological products, (no disgnostic substances)
This Founders Agreement (the “Agreement”) is entered into as of June 1, 2011, by and between Shai Yarkoni, an individual bearing Israeli passport 55365860 and Nadir Ashkenazi, an individual bearing Israeli I.D. 14692909 and Kasian Nuriel Chirich, an individual bearing Israeli I.D. 55483143. (Each of the individuals shall be referred to as a “Party” or “Shareholder” and collectively, the “Parties” or “Shareholders”.
